2888 related articles for article (PubMed ID: 6365305)
1. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma.
van Duinen SG; Ruiter DJ; Hageman P; Vennegoor C; Dickersin GR; Scheffer E; Rümke P
Cancer; 1984 Apr; 53(7):1566-73. PubMed ID: 6365305
[TBL] [Abstract][Full Text] [Related]
2. A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sections.
Palmer AA; Hall BE; Lew M
Pathology; 1985 Apr; 17(2):335-9. PubMed ID: 3900899
[TBL] [Abstract][Full Text] [Related]
3. Amelanotic melanoma: cases studied by Fontana stain, S-100 immunostain, and ultrastructural examination.
Gibson LE; Goellner JR
Mayo Clin Proc; 1988 Aug; 63(8):777-82. PubMed ID: 2456432
[TBL] [Abstract][Full Text] [Related]
4. The use of antikeratin antibodies in the immunohistochemical distinction between neuroendocrine (Merkel cell) carcinoma of the skin, lymphoma, and oat cell carcinoma.
Battifora H; Silva EG
Cancer; 1986 Sep; 58(5):1040-6. PubMed ID: 2425928
[TBL] [Abstract][Full Text] [Related]
5. Balloon cell malignant melanoma of the skin. A clinicopathologic study of 34 cases with histochemical, immunohistochemical, and ultrastructural observations.
Kao GF; Helwig EB; Graham JH
Cancer; 1992 Jun; 69(12):2942-52. PubMed ID: 1591688
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies in detection of choroidal melanoma.
Ringens PJ; van Haperen R; Vennegoor C; de Jong PT; van Duinen SG; Ruiter DJ; van der Kamp AW
Graefes Arch Clin Exp Ophthalmol; 1989; 227(3):287-90. PubMed ID: 2661335
[TBL] [Abstract][Full Text] [Related]
7. Morphologic diversity in malignant melanomas.
Nakhleh RE; Wick MR; Rocamora A; Swanson PE; Dehner LP
Am J Clin Pathol; 1990 Jun; 93(6):731-40. PubMed ID: 2346132
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous amelanotic melanomas of the uveal tract in F344 rats.
Yoshitomi K; Boorman GA
Vet Pathol; 1991 Sep; 28(5):403-9. PubMed ID: 1750166
[TBL] [Abstract][Full Text] [Related]
9. Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis.
Walts AE; Said JW; Shintaku IP
Am J Clin Pathol; 1988 Jul; 90(1):77-80. PubMed ID: 2455446
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections.
Kaufmann O; Koch S; Burghardt J; Audring H; Dietel M
Mod Pathol; 1998 Aug; 11(8):740-6. PubMed ID: 9720502
[TBL] [Abstract][Full Text] [Related]
11. Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections.
Hagen EC; Vennegoor C; Schlingemann RO; van der Velde EA; Ruiter DJ
Histopathology; 1986 Jul; 10(7):689-700. PubMed ID: 2427431
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody specific for cells of the melanocyte lineage.
Vennegoor C; Hageman P; Van Nouhuijs H; Ruiter DJ; Calafat J; Ringens PJ; Rümke P
Am J Pathol; 1988 Jan; 130(1):179-92. PubMed ID: 3276209
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of melanoma-associated antigens on formalin-fixed, paraffin-embedded canine tumors.
Berrington AJ; Jimbow K; Haines DM
Vet Pathol; 1994 Jul; 31(4):455-61. PubMed ID: 7941235
[TBL] [Abstract][Full Text] [Related]
14. Cytodiagnosis of amelanotic metastatic malignant melanoma: an immunocytochemical study.
Gupta RK; Lallu S
Diagn Cytopathol; 1997 Mar; 16(3):238-41. PubMed ID: 9099545
[TBL] [Abstract][Full Text] [Related]
15. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma.
House NS; Fedok F; Maloney ME; Helm KF
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 2):839-42. PubMed ID: 7525666
[TBL] [Abstract][Full Text] [Related]
16. Specification and use of a mouse monoclonal antibody raised against melanosomes for the histopathologic diagnosis of amelanotic malignant melanoma.
Maeda K; Maeda K; Jimbow K
Cancer; 1988 Sep; 62(5):926-34. PubMed ID: 3044572
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance.
Natali PG; Roberts JT; Difilippo F; Bigotti A; Dent PB; Ferrone S; Liao SK
Cancer; 1987 Jan; 59(1):55-63. PubMed ID: 3539308
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of melanocytic differentiation antigens in cutaneous malignant melanoma. A comparison of six commercial antibodies and one non-commercial antibody in nodular melanoma, superficially spreading melanoma and lentigo maligna melanoma.
Kocan P; Jurkovic I; Böör A; Dudríková K; Krajcár R; Benický M; Kromydaki A
Cesk Patol; 2004 Apr; 40(2):50-6. PubMed ID: 15233017
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal islet antibody HISL-19 as a tool in the diagnosis of neuroendocrine carcinomas of the skin.
Buxbaum P; Horvat G; Gamper C; Krisch K
Cancer Detect Prev Suppl; 1987; 1():263-8. PubMed ID: 3155378
[TBL] [Abstract][Full Text] [Related]
20. "Undifferentiated" large cell malignancies: an ultrastructural and immunocytochemical study.
Azar HA; Espinoza CG; Richman AV; Saba SR; Wang T
Hum Pathol; 1982 Apr; 13(4):323-33. PubMed ID: 7042529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
